PubMed:28260110 / 1760-1880 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T13","span":{"begin":0,"end":120},"obj":"DRI_Background"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-entities","denotations":[{"id":"12474","span":{"begin":26,"end":32},"obj":"ChemicalEntity"},{"id":"12475","span":{"begin":37,"end":46},"obj":"ChemicalEntity"},{"id":"12476","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A38","pred":"db_id","subj":"12474","obj":"MESH:D004642"},{"id":"A39","pred":"db_id","subj":"12475","obj":"MESH:D002569"},{"id":"A40","pred":"db_id","subj":"12476","obj":"NCBIGene:2194"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-sentences","denotations":[{"id":"T14","span":{"begin":0,"end":120},"obj":"Sentence"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T52","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"},{"id":"T53","span":{"begin":66,"end":75},"obj":"GeneOrGeneProduct"},{"id":"T54","span":{"begin":109,"end":119},"obj":"GeneOrGeneProduct"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T30","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"},{"id":"T31","span":{"begin":66,"end":75},"obj":"GeneOrGeneProduct"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T13","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T37","span":{"begin":26,"end":32},"obj":"ChemicalEntity"},{"id":"T40","span":{"begin":37,"end":46},"obj":"ChemicalEntity"},{"id":"T42","span":{"begin":61,"end":65},"obj":"ChemicalEntity"}],"attributes":[{"id":"A37","pred":"ID:","subj":"T37","obj":"D004642"},{"id":"A38","pred":"ID:","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_77659"},{"id":"A39","pred":"ID:","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_42223"},{"id":"A40","pred":"ID:","subj":"T40","obj":"D002569"},{"id":"A41","pred":"ID:","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_171741"},{"id":"A42","pred":"ID:","subj":"T42","obj":"D064429"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T42","span":{"begin":61,"end":65},"obj":"ChemicalEntity"},{"id":"T40","span":{"begin":37,"end":46},"obj":"ChemicalEntity"},{"id":"T37","span":{"begin":26,"end":32},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A42","pred":"ID:","subj":"T42","obj":"D064429"},{"id":"A41","pred":"ID:","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_171741"},{"id":"A40","pred":"ID:","subj":"T40","obj":"D002569"},{"id":"A39","pred":"ID:","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_42223"},{"id":"A38","pred":"ID:","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_77659"},{"id":"A37","pred":"ID:","subj":"T37","obj":"D004642"}],"text":"The combined treatment of emodin and cerulenin, a commercial FASN inhibitor, had an additive effect on these activities."}